Rare diseases
Investigational molecules
Locations
Avinguda Del Parc Tecnologic 3, Parc Tecnologic Del Valles, Cerdanyola Del Valles, 08290 Barcelona, Spain
Ability Pharmaceuticals S.A. concentrates its research efforts on developing innovative treatments for malignant neoplasms, with a particular emphasis on addressing advanced solid tumors. The company's therapeutic approach targets patients with refractory cancers who have exhausted conventional treatment options, representing a critical unmet medical need in oncology.
The sponsor's research portfolio demonstrates a commitment to expanding therapeutic possibilities for patients with treatment-resistant malignancies, exploring mechanisms that may offer new pathways for clinical intervention in challenging oncological scenarios.
Ability Pharmaceuticals S.A. runs clinical trials in conditions such as Pancreatic carcinoma metastatic, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
